期刊文献+

趋化因子与子痫前期发病关系的研究进展 被引量:5

原文传递
导出
摘要 子痫前期是妊娠期特发性疾病,可累及全身各器官,严重者可导致母儿死亡。母胎免疫耐受机制的破坏被认为是子痫前期发病的重要原因之一,同时,血管内皮损伤也参与了子痫前期发病的重要环节。趋化因子是一类具有诱导白细胞定向迁移和活化作用的细胞因子,研究发现,趋化因子不仅在母胎界面免疫耐受中发挥作用,还参与胎盘部位血管生成、胚胎植入等过程。妊娠过程中趋化因子及其受体的表达异常可能导致母胎免疫耐受机制破坏,以及滋养细胞侵袭过浅使胎盘血管重铸障碍,进而引起胎盘缺血缺氧、血管内皮损伤,导致子痫前期的发病。本文就近年来趋化因子与子痫前期发病关系的研究进行综述。
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2014年第7期550-552,共3页 Chinese Journal of Obstetrics and Gynecology
基金 教育部高等学校博士点基金(20110181110010):四川省科技支撑计划(2013SZ0074) 成都市科技攻关计划(12PPYB097SF-002)
  • 相关文献

参考文献27

  • 1Youn BS,Mantel C,Broxmeyer HE.Chemokines,chemokine receptors and hematopoiesis[]].Immunol Rev,2000,177:150-174.
  • 2Honlk R.Chemokines beyond inflammation[J].Nature,1998,393:524-525.
  • 3Gelmini S,Mangoni M,Castiglione F,et al.The CXCR4/CXCL12 axis in endometrial cancer[J].Clin Exp Metastasis,2009,26:261-268.
  • 4Xu Y,Liu L,Qiu X,et al.CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells[J].PLoS One,2012,7:e33262.
  • 5Norman JE,Mackenzie F,Owen P,et al.Progesterone for the prevention of preterm birth in twin pregnancy(STOPPIT):a randomised,double-blind,placebo-controlled study and meta-analysis[J].Lancet.2009.373:2034-2040.
  • 6白晓霞,孔北华,张友忠,曲迅,王华丽.早孕蜕膜及绒毛组织中趋化因子CXC受体3、4及其配体的表达变化和意义[J].中华妇产科杂志,2008,43(12):904-908. 被引量:8
  • 7Kuang H,Chen Q,Fan X,et al.CXCL14 inhibits trophoblast outgrowth via a paracrine/autocrine manner during early pregnancy in mice[J].J Cell Physiol,2009,221:448-457.
  • 8Lockwood C J,Matta P,Krikun G,et al.Regulation of monoeyte chemoattraetant protein-1 expression by tumor neerosis factor-alpha and interleukin-1beta in first trimester human decidual cells:implications for preeelampsia[J].Am J Pathol,2006,168:445-452.
  • 9James JL,Whitley GS,Cartwright JE.Pre-eclampsia:fitting together the placental,immune and cardiovascular pieees[J].J Pathol,2010.221:363-378.
  • 10何晓宇,林晶,许波.MCP-1在妊娠期高血压疾病患者血清中的变化及意义[J].中国优生与遗传杂志,2012,20(4):21-23. 被引量:2

二级参考文献21

  • 1Hanna J, Wald O, Goldman-Wohl D, et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16^- human natural killer cells. Blood, 2003,102 : 1569-1577.
  • 2Red-Horse K, Drake PM, Gunn MD,et al. Chemokine ligand and receptor expression in the pregnant uterus: reciprocal patterns in complementary cell subsets suggest functional roles. Am J Pathol, 2001,159:2199-2213.
  • 3Nagler A, Lanier LL, Cwirla S, et al. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol, 1989,143:3183-3191.
  • 4Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immuuol, 2001,22:633-640.
  • 5King A. Uterine leukocytes and deeidualization. Hum Reprod Update, 2000,6:28-36.
  • 6Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens, 2004,63 : 1-12.
  • 7Wu X, Jin LP, Yuan MM, et al. Human first-trimester trophoblast cells recruit CD56^bright CD16^- NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor. J Immunol, 2005,175:61-68.
  • 8Daikoku N, Kitaya K, Nakayama T, et al. Expression of macrophage inflammatory protein-3beta in human endometrium throughout the menstrual cycle. Fertil Steril, 2004,81 : 876-881.
  • 9ANDRA.S SZARKA, JANOS RIGAJR, LEVENTE LAZ/:R, et al. Circulating cytokines, chemokines and adhesion mole- cules in normal pregnancy and preeclampsia determined by multiplex suspension array[J]. BMC Immunol, 2010,11: 59.
  • 10MOLVAREC A, SZARKA A, WALENTIN S, et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecul d angiogenic factors in normal pregnancy and preeclampsia[J]. Reprod Biol Endocrinol, 2011,9 : 124.

共引文献9

同被引文献39

  • 1邝秋琼.早发型和晚发型重度子痫前期分娩方式及母婴结局分析[J].实用妇科内分泌电子杂志,2019,0(21):68-68. 被引量:3
  • 2黄秀永.妊娠期高血压疾病护理的研究[J].医学信息(医学与计算机应用),2014,0(11):548-548. 被引量:2
  • 3Yin N, Zhang H, Luo X, et al. IL-27 activates human troph- oblasts to express IP-10 and IL-6: implications in the immu- nopathophysiology of preeclampsia [ J 3. Mediators Inflamm, 2014, 2014: 926875.
  • 4Svensson-Arvelund J, Ernerudh J, Buse E, et al. The pla- centa in toxicology. Part II : systemic and local immune adap- tations in pregnancy [ J 1. Toxicol Pathol, 2014, 42 (2) : 327 -338.
  • 5Molvarec A, Szarka A, Walentin S, et al. Serum teptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and pre- eclampsia [J]. Reprod Biol Endocrinol, 2011, 9: 124.
  • 6Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia [ J 1. J Leukoc Biol, 2013, 94 (2): 247-257.
  • 7Kovo M, Schreiber L, Elyashiv O, et al. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia [ J 1- Re- prodSci, 2015, 22 (3): 316-321.
  • 8Than NG,Abdul Rahman O,Magenheim R,et al.Placental protein13(galectin-13)has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting w ith preterm pre-eclampsia and HELLP syndrome[J].Virchows Arch,2008,453(4):387-400.
  • 9Hayes E,Dominguez C,Voelkel S,et al.Effect of glycodelin on the production of vascular endothelial growth factor in cumulus cells[J].Ferrtil steril,2013,85(5):1553-1556.
  • 10Huppertz B,Sammar M,Chefetz I,et al.Longitudinal determination of serum placental protein 13 during development of preeclampsia[J].Fetal Diagn Ther,2011,24(3):230-236.

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部